Skip to Content

Join the 'Prandin' group to help and get support from people like you.

Prandin News

Early Menopause May Be Tied to Type 2 Diabetes

Posted 7 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – The earlier a woman begins menopause, the greater her risk of developing diabetes, a new study suggests. Following almost 4,000 women in the Netherlands, Dutch researchers found that those who went through menopause before age 40 were almost four times as likely to develop type 2 diabetes as women whose menopause was late – at 55 or older. The average age for menopause in the United States is 51, according to the National Institute on Aging. Overall, the risk of developing diabetes fell 4 percent for each added year before menopause, according to the study. "Early onset of [natural menopause] is an independent marker for [type 2 diabetes] in postmenopausal women," wrote Dr. Taulant Muka and colleagues at Erasmus University Medical Center in Rotterdam. Their results were published July 18 in the journal Diabetologia. The study doesn't show a direct ... Read more

Related support groups: Diabetes, Type 2, Hot Flashes, Menopausal Disorders, Glipizide, Postmenopausal Symptoms, Insulin Resistance, Janumet, Glyburide, Pre-Diabetes, Glimepiride, Atrophic Vaginitis, Amaryl, Perimenopausal Symptoms, Diabetes Mellitus, Prandin, GlipiZIDE XL, Glucotrol, ActoPlus Met, Dyspareunia, Glucotrol XL

New Diabetes Treatment Teaches Rogue Immune Cells to Behave

Posted 12 days ago by Drugs.com

FRIDAY, July 14, 2017 – A treatment targeting wayward immune cells in people with type 1 or type 2 diabetes may help even years later, a new study finds. For the treatment, researchers take blood from a person with diabetes and separate out the immune system cells (lymphocytes). They briefly expose those cells to stem cells from umbilical cord blood from an unrelated infant. Then they return the lymphocytes to the patient's body. The researchers have dubbed this treatment "stem cell educator therapy," because when exposed to the stem cells, the errant lymphocytes seem to re-learn how they should behave. "Stem cell educator therapy is a safe approach" with long-term effectiveness, said the study's lead author, Dr. Yong Zhao. He's an associate scientist at Hackensack University Medical Center in New Jersey. Type 1 diabetes, an autoimmune disease, occurs when the body's immune system ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Diabetes, Type 1, Glipizide, Glucophage, Novolog, Humalog, Insulin Resistance, Glyburide, Lantus Solostar, Levemir, Actos, Pre-Diabetes, Glimepiride, Novolin R, Amaryl, Novolin N, Pioglitazone

Exercising Safely With Diabetes

Posted 19 days ago by Drugs.com

FRIDAY, July 7, 2017 – Exercise is a powerful tool for managing diabetes. Doing it safely can be a bit of a challenge, but the extra effort is worth it. Regular exercise has been shown to lower blood sugar levels. Working out uses sugar from your bloodstream to fuel your muscles. It also helps the insulin in your body to work better, according to the American Diabetes Association. Talk to your doctor about which activities are safe for you, what your blood sugar readings should be prior to working out, and what to look for when you test your blood sugar during as well as after exercise. You'll likely be told to always test your blood sugar before working out. If it's too high to exercise safely, wait until it's back under control. If it's too low, eat a small snack to help prevent hypoglycemia – dangerously low blood sugar, the U.S. Centers for Disease Control and Prevention ... Read more

Related support groups: Metformin, Insulin, Lantus, Glipizide, Glucophage, Novolog, Humalog, Insulin Resistance, Glyburide, Invokana, Lantus Solostar, Levemir, Actos, Pre-Diabetes, Glimepiride, Novolin R, Amaryl, Novolin N, Pioglitazone, Diabetes Mellitus

Dealing With Diabetes Distress

Posted 16 Feb 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – People with diabetes have to think about their condition and make treatment decisions constantly – and all that extra work and worry can lead to psychological distress at times. "Diabetes distress" isn't the same as depression, however, diabetes experts note. It's a condition unique to the 24/7 demands that come with diabetes, particularly for people dependent on insulin. "The day you develop diabetes, it's like the universe just handed you a new full-time job that you have to do in addition to whatever else you're doing. It's a special job that has a big impact on the rest of your life. There's no pay and no vacation," said William Polonsky, president of the Behavioral Diabetes Institute in San Diego. Alicia McAuliffe-Fogarty, vice president of lifestyle management at the American Diabetes Association, put it this way: "Diabetes distress is the extra burden ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Diabetes, Type 1, Glipizide, Glucophage, Novolog, Humalog, Insulin Resistance, Janumet, Glyburide, Invokana, Lantus Solostar, Levemir, Actos, Pre-Diabetes, Glimepiride, Novolin R, Amaryl

Air Pollution May Raise Risk of Type 2 Diabetes

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – High levels of air pollution may increase some Hispanic children's risk of type 2 diabetes, a new study suggests. "Exposure to heightened air pollution during childhood increases the risk for Hispanic children to become obese and, independent of that, to also develop type 2 diabetes," said study corresponding author Michael Goran. He is co-director of the University of Southern California's Diabetes and Obesity Research Institute. "Poor air quality appears to be a catalyst for obesity and diabetes in children, but the conditions probably are forged via different pathways," Goran said in a university news release. For the study, researchers followed 314 overweight or obese Hispanic children in Los Angeles County. The children were between 8 and 15 years old when the study started. None had diabetes. By the time children who lived in areas with high levels of air ... Read more

Related support groups: Diabetes, Type 2, Cough, Metformin, Asthma, Insulin, Bronchitis, Lantus, Tonsillitis/Pharyngitis, Glipizide, Glucophage, Novolog, Humalog, Dyspnea, Upper Respiratory Tract Infection, Glyburide, Lantus Solostar, Levemir, Glimepiride, Cough and Nasal Congestion, Novolin R

Sickle Cell Trait in Blacks Can Skew Diabetes Test Results

Posted 7 Feb 2017 by Drugs.com

TUESDAY, Feb. 7, 2017 – A blood test commonly used to diagnose and treat diabetes may be less accurate in black people who have the sickle cell anemia trait, a new study says. The test is called hemoglobin A1C (HbA1C). An A1C reading of 5.7 or more indicates prediabetes or diabetes; below 5.7 is normal, says the American Diabetes Association. But, the current study found that for blacks with a trait for sickle cell anemia, the A1C test may come back lower than it should. This discrepancy could lead to delays in diagnosis and treatment of diabetes, and it might also affect the management of known diabetes. When the researchers compared the results of A1C tests to other measures that check blood sugar levels, they showed that when A1C readings were expected to be 6 percent, they only registered 5.7 percent for blacks with sickle cell trait. "We want to make clinicians aware that things ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Glipizide, Glucophage, Novolog, Humalog, Insulin Resistance, Glyburide, Lantus Solostar, Levemir, Pre-Diabetes, Glimepiride, Novolin R, Amaryl, Anemia - Sickle Cell, Novolin N, Diabetes Mellitus, Humulin N

Slim But Sedentary: Risk of Prediabetes May Rise

Posted 27 Jan 2017 by Drugs.com

FRIDAY, Jan. 27, 2017 – Here's yet another reason to get off the couch: Inactivity is associated with greater risk of prediabetes, even for healthy-weight adults, a new study finds. University of Florida researchers said the finding may help explain why up to one-third of slim American adults have prediabetes – elevated blood sugar but not full-blown diabetes. "We have found that a lot of people who we would consider to be at healthy weight – they're not overweight or obese – are not metabolically healthy," said lead investigator Arch Mainous III. He's chair of health services research, management and policy in the university's College of Public Health and Health Professions. Mainous and his colleagues analyzed data from more than 1,000 people, aged 20 and older, in England. All had a healthy weight and no diagnosis of diabetes. Those with an inactive lifestyle were more likely than ... Read more

Related support groups: Diabetes, Type 2, Obesity, Metformin, Insulin, Glipizide, Glucophage, Insulin Resistance, Glyburide, Pre-Diabetes, Glimepiride, Amaryl, Diabetes Mellitus, Glucophage XR, Prandin, GlipiZIDE XL, Glucotrol, Glucotrol XL, Glumetza, Repaglinide, Starlix

Diabetes Kills More Americans Than Had Been Thought

Posted 25 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 25, 2017 – The number of Americans who die from diabetes is much higher than previously believed, according to a new study. The research, based on federal government data, found that diabetes causes 12 percent of deaths in the United States. That makes it the third-leading cause of death after heart disease and cancer, researchers said. "Another way of saying that is, if diabetes were eliminated as a disease process, the number of deaths would decline by 12 percent," said study author Samuel Preston, a sociology professor at the University of Pennsylvania. "There has been only one similar, earlier research effort, and it was based on data from the 1980s and early '90s. It showed deaths attributable to diabetes amounted to roughly 4 percent of total deaths," he said in a university news release. Data for the new study came from the U.S. National Health Interview Survey ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Heart Disease, Lantus, Glipizide, Glucophage, Novolog, Humalog, Insulin Resistance, Glyburide, Lantus Solostar, Levemir, Actos, Pre-Diabetes, Glimepiride, Novolin R, Amaryl, Novolin N, Pioglitazone

Language Barrier May Keep Some Hispanics From Good Diabetes Care

Posted 23 Jan 2017 by Drugs.com

MONDAY, Jan. 23, 2017 – Hispanic-American type 2 diabetes patients who lack proficiency in English may end up with poorer care, a new study finds. Specifically, these patients were found to be much less likely than non-Hispanic patients to take newly prescribed diabetes medications as directed, the researchers said. The study "suggests that more needs to be done to improve adherence to newly prescribed medications among Latino patients at all levels of English proficiency," wrote a team led by Dr. Alicia Fernandez, of the University of California, San Francisco. A diabetes specialist who reviewed the study wasn't surprised by the results. The research "further validates what many clinicians already know: Patients who do not understand English tend to do worse with management of chronic disease," said Dr. Maria Pena. She is an endocrinologist who directs the Center for Weight Management ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Diabetes, Type 1, Glipizide, Glucophage, Novolog, Humalog, Insulin Resistance, Janumet, Glyburide, Invokana, Lantus Solostar, Levemir, Actos, Pre-Diabetes, Glimepiride, Novolin R, Amaryl

Intensive Type 2 Diabetes Treatment Can Extend Survival: Study

Posted 8 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Intensive management of type 2 diabetes can make a difference in how long and how well you live, even if you don't start until middle age, researchers report. People who were already at risk of type 2 diabetes complications were randomly selected to continue with their normal treatment or to be placed in an aggressive and multipronged treatment group. Two decades after the study began, the researchers found that people in the aggressive treatment group lived almost eight years longer. Not only that, they lived better – their risk of heart disease, kidney disease and blindness all dropped. The only complication that didn't seem to improve was nerve damage caused by diabetes. "Early, intensified intervention in type 2 diabetes patients with microalbuminuria with both target-driven pharmacological (medication) and behavioral actions increased life span. And, ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Januvia, Glucophage, Saxenda, Glipizide, Novolog, Humalog, Bydureon, Janumet, Byetta, Glyburide, Invokana, Lantus Solostar, Levemir, Actos, Trulicity

Intensive Blood Sugar Control May Be Too Much for Some With Type 2 Diabetes

Posted 6 Jun 2016 by Drugs.com

MONDAY, June 6, 2016 – Intensive treatment of blood sugar levels in some people with type 2 diabetes may cause serious complications, new research suggests. "In this study, we found that, particularly among older patients and patients with serious chronic conditions, intensive treatment nearly doubled the risk of severe hypoglycemia requiring medical attention, including hospitalization," said lead author Dr. Rozalina McCoy. She is an endocrinologist at the Mayo Clinic in Rochester, Minn. Hypoglycemia (low blood sugar) is a serious potential complication of diabetes treatment. The researchers said it can worsen quality of life and has been linked with cardiovascular events, dementia and death. The researchers reviewed information from more than 31,500 American adults. All had stable and controlled type 2 diabetes. None was taking insulin. None had a prior history of severe ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Dementia, Lantus, Glipizide, Glucophage, Novolog, Humalog, Hypoglycemia, Janumet, Glyburide, Invokana, Lantus Solostar, Levemir, Actos, Glimepiride, Novolin R, Amaryl, Novolin N

Cost of Insulin Rises Threefold in Just a Decade: Study

Posted 5 Apr 2016 by Drugs.com

TUESDAY, April 5, 2016 – Americans with diabetes who rely on insulin to keep their blood sugar levels in check are facing sticker shock: A new study finds the price of insulin has tripled in only 10 years. Moreover, since 2010, per-person spending on insulin in the United States was more than spending on all other diabetes drugs, the study found. "The cost of insulin has risen rapidly over the last few years," said study senior author Philip Clarke, a professor of health economics at the University of Melbourne in Australia. Clarke added there should be an assessment to see whether this price hike is justifiable in terms of improved clinical outcomes. One reason for the price climb, he said, is a switch from human insulins to analog insulins, which cost more but may offer additional benefits. Also, doctors are more apt to prescribe insulin for people with type 2 diabetes now, Clarke ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Diabetes, Type 1, Januvia, Diabetic Neuropathy, Saxenda, Glucophage, Glipizide, Novolog, Humalog, Insulin Resistance, Bydureon, Janumet, Diabetic Nerve Damage, Byetta, Glyburide, Invokana

Diabetes Meds Vary in Safety and Effectiveness, Study Shows

Posted 31 Mar 2016 by Drugs.com

THURSDAY, March 31, 2016 – A study of nearly a half-million people with type 2 diabetes shows there are pros and cons to nearly every form of drug therapy for the disease. In the British study, researchers looked at patient outcomes from a large U.K. database of almost 470,000 adults with type 2 diabetes, tracked between 2007 and 2015. Julia Hippisley-Cox and Carol Coupland, of the University of Nottingham, sought to parse out differences among a variety of diabetes drugs. They accounted for complicating patient factors such as age, sex, smoking and poverty, as well as how long a person had been diagnosed with type 2 diabetes. The researchers also focused on five major outcomes linked to diabetes: blindness, amputation, severe kidney failure, and high or low blood sugar. Reporting March 30 in BMJ, they found that when a class of drugs called glitazones (Actos, Avandia) was prescribed ... Read more

Related support groups: Diabetes, Type 2, Metformin, Glipizide, Glucophage, Insulin Resistance, Janumet, Glyburide, Actos, Pre-Diabetes, Glimepiride, Amaryl, Diabetes Mellitus, Avandia, Glucophage XR, Prandin, GlipiZIDE XL, Glucotrol, ActoPlus Met, Glucotrol XL, Glumetza

New Diabetes Cases Among Americans Drop for First Time in Decades: CDC

Posted 1 Dec 2015 by Drugs.com

TUESDAY, Dec. 1, 2015 – In a sign that Americans may finally be turning the corner in the fight against diabetes – and possibly obesity – federal health statistics released Tuesday show that the number of new cases of diabetes has dropped for the first time in decades. The decline wasn't sudden or dramatic. But, the number of new diabetes cases went from 1.7 million in 2009 to 1.4 million in 2014, according to the U.S. Centers for Disease Control and Prevention. "It seems pretty clear that incidence rates have now actually started to drop. Initially it was a little surprising because I had become so used to seeing increases everywhere we looked," CDC researcher Edward Gregg told The New York Times. The proportion of Americans with diabetes is still twice what it was in the early 1990s. And not every racial group has made strides against the blood sugar disease, which is often ... Read more

Related support groups: Diabetes, Type 2, Obesity, Metformin, Weight Loss, Insulin, Victoza, Lantus, Januvia, Glucophage, Glipizide, Saxenda, Novolog, Humalog, Bydureon, Janumet, Byetta, Glyburide, Invokana, Lantus Solostar, Levemir

Too Many Seniors With Diabetes Are Overtreated, Study Suggests

Posted 29 Oct 2015 by Drugs.com

THURSDAY, Oct. 29, 2015 – When it comes to treating seniors with diabetes, new research suggests that doctors often don't cut back on medications, even when treatment goals are surpassed. The study found that when people had potentially dangerous low blood sugar levels, just 27 percent had their medicines decreased. And when blood pressure treatments lowered blood pressure levels too much, just 19 percent saw a reduction in their medications. "As people get older, the risks of overtreating become greater, and the benefits become shorter. We have to start emphasizing that more isn't always better," said study author Dr. Jeremy Sussman, an assistant professor of internal medicine at the University of Michigan in Ann Arbor and a primary care doctor at the Ann Arbor VA System. The findings were published online Oct. 26 in the journal JAMA Internal Medicine. Practice guidelines generally ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Januvia, Glucophage, Glipizide, Saxenda, Novolog, Humalog, Bydureon, Janumet, Byetta, Glyburide, Invokana, Lantus Solostar, Levemir, Actos, Trulicity

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Diabetes, Type 2

Prandin Patient Information at Drugs.com